Evaluation of Two Types of Matrix (Mucograft® and Mucoderm®) Associated With Coronally Advanced Flap

Launched by UNIVERSIDADE ESTADUAL PAULISTA JÚLIO DE MESQUITA FILHO · Sep 10, 2018

Keywords

ClinConnect Summary

This is a prospective, parallel and controlled clinical trial. The population that will be evaluated in the study will be selected at Institute of Science and Technology (ICT), São José dos Campos, College of Dentistry.

Seventy-five patients presenting gingival recession will be divided in 3 groups:

* Group CAF + XDM (25): Periodontal surgery for root coverage through coronally advanced flap technique plus xenogenous dermal matrix graft Mucoderm®.
* Group CAF + MC (25): Periodontal surgery for root coverage through coronally advanced flap technique plus xenogenous collagen matrix graft Mu...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients presenting Miller class I or II gingival recession in the maxillary canines or premolars;
• • Teeth included in the study should present pulp vitality and no associated with carious or cervical lesion;
• • Patients presenting no signs of active periodontal disease and full-mouth plaque and bleeding score ≤ 20%;
• • Probing depth ˂ 3 mm in the included and adjacent teeth, presenting no signs of bleeding or attachment loss;
• • Patients older than 18 years old;
• • Patients who agreed to participate and signed an informed consent form.
• Exclusion Criteria:
• • Patients with systemic problems (cardiovascular, blood dyscrasias, immunodeficiency, and diabetes, among others) that will contraindicate the surgical procedure;
• • Patients taking medications known to interfere with the wound healing process or that contraindicate the surgical procedure;
• • pregnant or lactating women;
• • Smokers;
• • Patients who underwent periodontal surgery in the area of interest;
• • Patients with orthodontic therapy in progress.